Gastrointestinal side effects of NSAIDs - Pharmacoeconomic implications

Christopher L. Sheen; Thomas M. MacDonald

doi:10.1517/14656566.3.3.265

Gastrointestinal side effects of NSAIDs - Pharmacoeconomic implications

Christopher L. Sheen, Thomas M. MacDonald

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

NSAIDs are frequently used as analgesics. They have a high incidence of GI adverse effects that have both social and economic costs. These costs impose a considerable strain on healthcare resources. This review discusses the epidemiology and economic cost of these adverse GI events. It also highlights the variability in risk and the impact of newer drugs. Risk stratification and the subsequent guided use of NSAIDs is likely to limit the pharmacoeconomic implications.

Original language	English
Pages (from-to)	265-269
Number of pages	5
Journal	Expert Opinion on Pharmacotherapy
Volume	3
Issue number	3
DOIs	https://doi.org/10.1517/14656566.3.3.265
Publication status	Published - 2002

Keywords

Adverse effects
Gastrointestinal
NSAID
Pharmacoeconomics
Side effects

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1517/14656566.3.3.265

Cite this

@article{0b40010eaadd418d88442ac5b196c3e5,

title = "Gastrointestinal side effects of NSAIDs - Pharmacoeconomic implications",

abstract = "NSAIDs are frequently used as analgesics. They have a high incidence of GI adverse effects that have both social and economic costs. These costs impose a considerable strain on healthcare resources. This review discusses the epidemiology and economic cost of these adverse GI events. It also highlights the variability in risk and the impact of newer drugs. Risk stratification and the subsequent guided use of NSAIDs is likely to limit the pharmacoeconomic implications.",

keywords = "Adverse effects, Gastrointestinal, NSAID, Pharmacoeconomics, Side effects",

author = "Sheen, {Christopher L.} and MacDonald, {Thomas M.}",

year = "2002",

doi = "10.1517/14656566.3.3.265",

language = "English",

volume = "3",

pages = "265--269",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Taylor & Francis",

number = "3",

}

TY - JOUR

T1 - Gastrointestinal side effects of NSAIDs - Pharmacoeconomic implications

AU - Sheen, Christopher L.

AU - MacDonald, Thomas M.

PY - 2002

Y1 - 2002

N2 - NSAIDs are frequently used as analgesics. They have a high incidence of GI adverse effects that have both social and economic costs. These costs impose a considerable strain on healthcare resources. This review discusses the epidemiology and economic cost of these adverse GI events. It also highlights the variability in risk and the impact of newer drugs. Risk stratification and the subsequent guided use of NSAIDs is likely to limit the pharmacoeconomic implications.

AB - NSAIDs are frequently used as analgesics. They have a high incidence of GI adverse effects that have both social and economic costs. These costs impose a considerable strain on healthcare resources. This review discusses the epidemiology and economic cost of these adverse GI events. It also highlights the variability in risk and the impact of newer drugs. Risk stratification and the subsequent guided use of NSAIDs is likely to limit the pharmacoeconomic implications.

KW - Adverse effects

KW - Gastrointestinal

KW - NSAID

KW - Pharmacoeconomics

KW - Side effects

UR - http://www.scopus.com/inward/record.url?scp=0036192967&partnerID=8YFLogxK

U2 - 10.1517/14656566.3.3.265

DO - 10.1517/14656566.3.3.265

M3 - Article

C2 - 11866677

AN - SCOPUS:0036192967

SN - 1465-6566

VL - 3

SP - 265

EP - 269

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

IS - 3

ER -

Gastrointestinal side effects of NSAIDs - Pharmacoeconomic implications

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this